|
|
|
Volumn 15, Issue 3, 1995, Pages 265-271
|
|
Vertical integration: The drug industry and prescription benefits managers
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACICLOVIR;
ANTIHISTAMINIC AGENT;
ANXIOLYTIC AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
CAPTOPRIL;
CEFACLOR;
CIMETIDINE;
COLESTIPOL;
COLESTYRAMINE;
CYCLOSPORIN;
DILTIAZEM;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
FAMOTIDINE;
GLIBENCLAMIDE;
GLIPIZIDE;
HISTAMINE H2 RECEPTOR ANTAGONIST;
LISINOPRIL;
LORAZEPAM;
NIFEDIPINE;
NONSTEROID ANTIINFLAMMATORY AGENT;
OMEPRAZOLE;
ORAL CONTRACEPTIVE AGENT;
RANITIDINE;
TERFENADINE;
COMPETITION;
DRUG CHOICE;
DRUG INDUSTRY;
DRUG MANUFACTURE;
FOOD AND DRUG ADMINISTRATION;
GOVERNMENT;
HEALTH MAINTENANCE ORGANIZATION;
MARKETING;
PATENT;
PHARMACY;
PRESCRIPTION;
REFLUX ESOPHAGITIS;
REVIEW;
SUSTAINED RELEASE PREPARATION;
COMMERCE;
CONFLICT OF INTEREST;
DRUG COSTS;
DRUG INDUSTRY;
DRUGS, GENERIC;
ECONOMIC COMPETITION;
HUMAN;
MANAGED CARE PROGRAMS;
NEGOTIATING;
PRESCRIPTIONS, DRUG;
PRIMARY HEALTH CARE;
|
|
EID: 0029026657
PISSN: 02770008
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (4)
|
|
References (0)
|
